Read more

February 08, 2024
38 min listen
Save

Precision Medicine and Personalized Care with George Sledge, MD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this episode, host Shikha Jain, MD, speaks with George Sledge, MD, about patient feedback benefiting leadership decision-making, the future of precision medicine in oncology and more.

  • Welcome to another exciting episode of Oncology Overdrive :58
  • About Sledge 1:03
  • The interview 2:59
  • How did you become an oncologist? 3:24
  • Tell us about your journey into leadership in oncology. 5:27
  • Did you continue to see patients while leading organizations? 7:48
  • Jain and Sledge on learning from conversations and experiences with patients. 10:57
  • How did you end up in your previous position as ASCO president? 12:29
  • Do you feel that ASCO is an organization that is adept at adapting to change? 14:37
  • Tell us about Caris Life Sciences and how you pivoted to your role as executive vice president and CMO there. 18:44
  • Where do you see the future of oncology going? 23:00
  • Jain and Sledge on the concerns surrounding artificial intelligence and technology in cancer care and the doctor patient relationship. 26:31
  • What is something aspirational that you think could change the way we deliver cancer care years from now? 31:11
  • If someone could only listen to the last minute of this episode, what would you want them to take away? 35:21
  • How to contact Sledge 36:37
  • Thanks for listening 37:10

George Sledge, MD, serves as executive vice president and chief medical officer at Caris Life Sciences.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Sledge can be reached via email gsledge@carisls.com.

Sources/Disclosures

Collapse

Disclosures: Jain reports no relevant financial disclosures. Sledge reports that he has stock options with Syndax.